Actinium Pharmaceuticals
ATNM
#10413
Rank
C$40.55 M
Marketcap
C$1.29
Share price
3.58%
Change (1 day)
-44.91%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -C$52.85 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are C$0.09 Million. In 2024 the company made an earning of -C$59.06 Million, an increase over its 2023 earnings that were of -C$72.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$52.85 Million-10.51%
2024 -C$59.06 Million-18.87%
2023 -C$72.8 Million52.24%
2022 -C$47.82 Million36.61%
2021 -C$35 Million11.48%
2020 -C$31.4 Million1.46%
2019 -C$30.95 Million-7.37%
2018 -C$33.41 Million-11.46%
2017 -C$37.73 Million10.67%
2016 -C$34.1 Million15.7%
2015 -C$29.47 Million-14.86%
2014 -C$34.62 Million129.19%
2013 -C$15.11 Million-8.55%
2012 -C$16.52 Million
2010 C$0.01 M-152.15%
2009 -C$0.03 Million-39.8%
2008 -C$0.04 Million120.29%
2007 -C$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-C$52.15 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.26 M-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54 B-1,132.71%๐Ÿ‡บ๐Ÿ‡ธ USA